Cited by 146Lipoproteins and Cardiovascular HealthCancer, Lipids, and MetabolismCoronary Interventions and Diagnostics

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Statins for people at low risk of cardiovascular disease – Authors' reply

Mihaylova, Borislava, Emberson, Jonathan, Keech, Anthony, Collins, Rory, Baigent, Colin·2012·The Lancet

DOI 10.1016/s0140-6736(12)62027-3

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(12)62027-3

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
Collaborators, C. T. T. (. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60367-5 · Cited by 2,833
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations: A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology
Grundy, S. M., Pasternak, R., Greenland, P., Smith, S., & Fuster, V. (1999) · Circulation · doi:10.1161/01.cir.100.13.1481 · Cited by 1,315
Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20 536 people
Collaborative, H. P. S. (2006) · BMJ · doi:10.1136/bmj.38993.731725.be · Cited by 109
Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens
Prepared by the Cholesterol Treatment Trialists' (CTT) Collaboration (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80744-9 · Cited by 101
Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels
Heart Protection Study Collaborative Group (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.808469 · Cited by 72

Show all 5 references

Sorted by citations

Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Statin Use and Reduced Cancer-Related Mortality
Klop, C., Driessen, J. H. M., & de Vries, F. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1214827 · Cited by 725
Epidemiological studies of CHD and the evolution of preventive cardiology
Wong, N. D. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.26 · Cited by 677
The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity
Borén, J., & Williams, K. J. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000330 · Cited by 524
Effects of aerobic exercise on lipids and lipoproteins
Wang, Y., & Xu, D. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0515-5 · Cited by 436
Statins in the primary prevention of cardiovascular disease
Reiner, Ž. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.80 · Cited by 314
Atherosclerosis
Schaftenaar, F. H., Frodermann, V., Kuiper, J., & Lutgens, E. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000302 · Cited by 276
Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials
Zhang, X.-L., Zhu, Q.-Q., Zhu, L., Chen, J.-Z., Chen, Q.-H., Li, G.-N., Xie, J., Kang, L.-N., & Xu, B. (2015) · BMC Medicine · doi:10.1186/s12916-015-0358-8 · Cited by 260
Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease
Klarin, D. M., Program, V. A. M. V., Busenkell, E., Judy, R., Lynch, J. A., Levin, M. G., Haessler, J., Aragam, K. G., Chaffin, M. D., Haas, M., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0519-3 · Cited by 239
Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: a randomised controlled trial
Lockyer, S., Rowland, I. R., Spencer, J. P. E., Yaqoob, P., & Stonehouse, W. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1188-y · Cited by 237
Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017
Wein, T. H., Lindsay, M. P., Côté, R., Foley, N. C., Berlingieri, J., Bhogal, S. K., Bourgoin, A., Buck, B. H., Cox, J. L., Davidson, D., et al. (2017) · International Journal of Stroke · doi:10.1177/1747493017743062 · Cited by 227
Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis
Semb, A. G., Ikdahl, E., Wibetoe, G., Crowson, C. S., & Rollefstad, S. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0428-y · Cited by 221
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System
McFarland, A. J., Anoopkumar‐Dukie, S., Arora, D. S., Grant, G. D., McDermott, C., Perkins, A. V., & Davey, A. K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151120607 · Cited by 210
Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis
Macedo, A. F., Taylor, F. C., Casas, J. P., Adler, A. J., Prieto‐Merino, D., & Ebrahim, S. B. J. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-51 · Cited by 190
Improving prevention strategies for cardiometabolic disease
Sattar, N. A., Gill, J. M. R., & Alazawi, W. (2020) · Nature Medicine · doi:10.1038/s41591-020-0786-7 · Cited by 174
Clinical utility of polygenic risk scores for coronary artery disease
Klarin, D., & Natarajan, P. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00638-w · Cited by 152
Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk
His, M., Zelek, L. H., Deschasaux, M., Pouchieu, C., Kesse‐Guyot, E., Herçberg, S., Galan, P., Latino‐Martel, P., Blacher, J., & Touvier, M. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9884-5 · Cited by 145
Statins as Regulators of Redox State in the Vascular Endothelium: Beyond Lipid Lowering
Margaritis, M., Channon, K. M., & Antoniades, C. A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5430 · Cited by 149
Cardiovascular risk assessment: a global perspective
Zhao, D. H., Liu, J., Xie, W., & Qi, Y. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.28 · Cited by 143
2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation)
Committee for the Korean Guidelines for the Management of Dyslipidemia (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.46.3.275 · Cited by 123
Cheese consumption and risk of cardiovascular disease: a meta-analysis of prospective studies
Chen, G., Wang, Y., Tong, X., Szeto, I. M. Y., Smit, G., Li, Z., & Qin, L. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1292-z · Cited by 121
Demystifying the management of hypertriglyceridaemia
Watts, G. F., Ooi, E. M. M., & Chan, D. C. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.140 · Cited by 115
Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins
Pinho-Gomes, A. C., Reilly, S., Brandes, R. P., & Casadei, B. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5542 · Cited by 94
Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk
Gatell, J. M., Assoumou, L., Moyle, G. J., Waters, L. J., Johnson, M. A., Domingo, P., Fox, J., Martínez, E., Stellbrink, H., Guaraldi, G., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001675 · Cited by 94
Evidence-based goals in LDL-C reduction
Soran, H., Dent, R., & Durrington, P. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-016-1069-7 · Cited by 92
Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review
Canestaro, W. J., Austin, M. A., & Thummel, K. E. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.41 · Cited by 81
Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome
Srikanth, S., & DEEDWANIA, P. C. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0683-0 · Cited by 86
Modelling survival: exposure pattern, species sensitivity and uncertainty
Ashauer, R., Albert, C., Augustine, S., Nina Cedergreen, G., Charles, S., Ducrot, V., Focks, A., Gabsi, F., Gergs, A., Goussen, B., et al. (2016) · Scientific Reports · doi:10.1038/srep29178 · Cited by 76
Statins and the autonomic nervous system
Millar, P. J., & Floras, J. S. (2013) · Clinical Science · doi:10.1042/cs20130332 · Cited by 75
Statins for primary prevention of cardiovascular disease
Minder, C. M., Blumenthal, R. S., & Blaha, M. J. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32836429e6 · Cited by 67
Synergistic effect of phytochemicals on cholesterol metabolism and lipid accumulation in HepG2 cells
Leng, E., Yuan, X., Mo, Z., Li, Y., Zhang, Y., Deng, X., Zhou, M., Zhou, C., He, Z., He, J., et al. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2189-6 · Cited by 69
Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trials
Colhoun, H. M., Robinson, J. G., Farnier, M., Cariou, B., Blom, D. J., Kereiakes, D. J., Lorenzato, C., Pordy, R. C., & Chaudhari, U. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-121 · Cited by 61
Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial
Verhoeven, V., Hartmann, M. L., Remmen, R., Wens, J., Apers, S., & Royen, P. V. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-178 · Cited by 60
Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review
Bruckert, É., Parhofer, K. G., González‐Juanatey, J. R., Nordestgaard, B. G., Arca, M., Giovas, P. P., & Ray, K. K. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01285-2 · Cited by 59
Adding a life-course perspective to cardiovascular-risk communication
Karmali, K. N., & Lloyd‐Jones, D. M. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.185 · Cited by 57
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM)
Bertoluci, M. C., Moreira, R. O., Faludi, A. Á., Izar, M. C. D. O., Schaan, B. D., Valério, C. M., Bertolami, M. C., Chacra, A. P. M., Malachias, M. V. B., Vencio, S. A. C., et al. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0251-z · Cited by 59
Seventeen Years of Statin Pharmacogenetics: a Systematic Review
Leusink, M., Onland‐Moret, N. C., de Bakker, P. I. W., de Boer, A., & der Zee, A. H. M. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.158 · Cited by 56
Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?
de Lorgeril, M., Salen, P., Defaye, P., & Rabaeus, M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-5 · Cited by 53
Comparison of cardiovascular disease risk calculators
Allan, G. M., Garrison, S., & McCormack, J. P. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000095 · Cited by 48
Tendinopathy and Tendon Rupture Associated with Statins
Deren, M. E., Klinge, S. A., Mukand, N. H., & Mukand, J. A. (2016) · JBJS Reviews · doi:10.2106/jbjs.rvw.15.00072 · Cited by 46
Hyperlipidemia is associated with lower risk of poststroke mortality independent of statin use: A population-based study
Yeramaneni, S., Kleindorfer, D., Sucharew, H. J., Alwell, K., Moomaw, C. J., Flaherty, M. L., Woo, D., Adeoye, O. M., Ferioli, S., Rosa, F. D. L. R. L., et al. (2016) · International Journal of Stroke · doi:10.1177/1747493016670175 · Cited by 47
Monitoring of lipids, enzymes, and creatine kinase in patients on lipid-lowering drug therapy
Wiklund, O., Pirazzi, C., & Romeo, S. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0397-8 · Cited by 45
Genetic susceptibility, elevated blood pressure, and risk of atrial fibrillation: a Mendelian randomization study
Nazarzadeh, M., Pinho‐Gomes, A., Bidel, Z., Canoy, D., Dehghan, A., Smith-Byrne, K., Bennett, D., Smith, G. D., & Rahimi, K. (2021) · Genome Medicine · doi:10.1186/s13073-021-00849-3 · Cited by 46
Recent advances in cardiovascular disease research driven by metabolomics technologies in the context of systems biology
Zhang, B., & Schmidlin, T. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00028-z · Cited by 48
Pharmacotherapies for lipid modification: beyond the statins
Gotto, A. M., & Moon, J. E. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.117 · Cited by 45
Statin use and risk of bladder cancer: a meta-analysis
Zhang, X., Geng, J., Zhang, X., Peng, B., Che, J., Yang, Y., Wang, G., Xia, S., Yan, W. S., & Zheng, J. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0159-3 · Cited by 42
Red clover isoflavones enriched with formononetin lower serum LDL cholesterol—a randomized, double-blind, placebo-controlled study
Clifton-Bligh, P. B., Nery, M. L., Clifton-Bligh, R. J., Visvalingam, S., Fulcher, G. R., Byth, K., & Baber, R. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.207 · Cited by 42
Increased triglyceride/high-density lipoprotein cholesterol ratio may be associated with reduction in the low-density lipoprotein particle size: assessment of atherosclerotic cardiovascular disease risk
Yokoyama, K., Tani, S., Matsuo, R., & Matsumoto, N. (2018) · Heart and Vessels · doi:10.1007/s00380-018-1247-9 · Cited by 41
Unmet need in the hyperlipidaemia population with high risk of cardiovascular disease: a targeted literature review of observational studies
Mitchell, S., Roso, S., Samuel, M., & Pladevall-Vila, M. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0241-3 · Cited by 40
Efficient design of clinical trials and epidemiological research: is it possible?
Lauer, M. S., Gordon, D., Wei, G. S., & Pearson, G. D. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.60 · Cited by 37
Serum lipids and risk of obesity-related cancers in postmenopausal women
Kabat, G. C., Kim, M., Chlebowski, R. T., Vitolins, M. Z., Wassertheil-Smoller, S. W., & Rohan, T. E. (2017) · Cancer Causes & Control · doi:10.1007/s10552-017-0991-y · Cited by 37
Cholesteryl ester transfer protein inhibitors: challenges and perspectives
Filippatos, T. D., Klouras, E., Barkas, F., & Elisaf, M. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2016.1189327 · Cited by 34
Role of Small GTPase Protein Rac1 in Cardiovascular Diseases
Ferri, N., Contini, A., Bernini, S. K., & Corsini, A. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182a18bcc · Cited by 34
Approach to Statin Use in 2016: an Update
Miller, P. E., & Martin, S. S. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0578-1 · Cited by 32
Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy?
Navarese, E. P., Szczesniak, A. M., Kołodziejczak, M. M., Górny, B., Kubica, J., & Suryapranata, H. (2013) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-013-0053-0 · Cited by 32
Greater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury: potential role as a histone deacetylase inhibitor
Singh, R. S., Chaudhary, D. K., Mohan, A., Kumar, P., Chaturvedi, C. P., ECELBARGER, C. A., Godbole, M. M., & Tiwari, S. (2016) · Scientific Reports · doi:10.1038/srep38034 · Cited by 32
Treatment Gap in the National Health-screening Program in Korea: Claim-based Follow-up of Statin Use for Sustained Hypercholesterolemia
Ahn, E., Shin, D. W., Yang, H. K., Yun, J. M., Chun, S., Suh, B., Lee, H., Son, K. Y., & Cho, B. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.9.1266 · Cited by 31
Statins to improve cardiovascular outcomes in treated HIV infection
Longenecker, C. T., Eckard, A. R., & McComsey, G. A. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000223 · Cited by 31
Vaccine strategies for lowering LDL by immunization against proprotein convertase subtilisin/kexin type 9
Chackerian, B., & Remaley, A. T. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000312 · Cited by 29
Association of classical risk factors and coronary artery disease in type 2 diabetic patients submitted to coronary angiography
Bittencourt, C., Piveta, V. M., Oliveira, C. S. V., Crispim, F., Meira, D. M., Saddi-Rosa, P., Giuffrida, F. M. A., & Reis, A. F. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-46 · Cited by 29
Communicating statin evidence to support shared decision-making
Barrett, B. P., Ricco, J. A., Wallace, M., KIEFER, D. M., & Rakel, D. (2016) · BMC Family Practice · doi:10.1186/s12875-016-0436-9 · Cited by 27
Hypothetical interventions to prevent stroke: an application of the parametric g-formula to a healthy middle-aged population
Vangen-Lønne, A. M., Ueda, P., Gulayin, P., Wilsgaard, T., Mathiesen, E. B., & Danaei, G. (2018) · European Journal of Epidemiology · doi:10.1007/s10654-017-0344-x · Cited by 26
Early postpartum dyslipidemia and its potential predictors during pregnancy in women with a history of gestational diabetes mellitus
Pei, L., Xiao, H., Lai, F., Li, Z., Li, Z., Yue, S., Chen, H., Li, Y., & Cao, X. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01398-1 · Cited by 28
Can atherosclerosis be cured?
Wilkins, J. T., Gidding, S. S., & Robinson, J. G. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000644 · Cited by 28
The efficacy and safety of ezetimibe coadministered with statin therapy in various patient groups
Catapano, A. L., Toth, P. P., Tomassini, J. E., & Tershakovec, A. M. (2013) · Clinical Lipidology · doi:10.2217/clp.12.88 · Cited by 26
Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly
Lin, L., Teng, M., Zhao, Y. J., Khoo, A. L., Seet, R. C. S., Yong, Q. W., Yeo, T. C., & Lim, B. P. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6584-7 · Cited by 24
Pharmacogenomics of Lipid-Lowering Therapies
Hu, M., & Tomlinson, B. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.71 · Cited by 24
Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland
Ingimarsson, O., MacCabe, J. H., Haraldsson, M. H., Jónsdóttir, H., & Sigurðsson, E. (2017) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2017.1334821 · Cited by 24
New insights into the role of glycosylation in lipoprotein metabolism
van den Boogert, M. A. W., Rader, D. J., & Holleboom, A. G. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000461 · Cited by 25
The optimal time of day for statin administration: a review of current evidence
Awad, K., & Banach, M. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000524 · Cited by 23
Safety considerations with fenofibrate/simvastatin combination
Filippatos, T. D., & Elisaf, M. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1056778 · Cited by 22
Treatment of Dyslipidemia and Cardiovascular Outcomes: The Journey So Far—Is This the End for Statins?
Zoungas, S., Curtis, A. J., McNeil, J. J., & Tonkin, A. M. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.86 · Cited by 22
Exercise-induced Myalgia may Limit the Cardiovascular Benefits of Statins
Opie, L. H. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-013-6483-8 · Cited by 21
Bio-inspired dual-functional phospholipid–poly(acrylic acid) brushes grafted porous poly(vinyl alcohol) beads for selective adsorption of low-density lipoprotein
Yu, Y., Dong, J., Ma, B., Jiang, X., Guo, C., Liu, Z., Chai, Y., Wang, L., Sun, L., Ou, L., et al. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01220g · Cited by 21
Mouse Models of Disturbed HDL Metabolism
Hoekstra, M., & Eck, M. V. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_9 · Cited by 23
Comparing the serum TAG response to high-dose supplementation of either DHA or EPA among individuals with increased cardiovascular risk: the ComparED study
Allaire, J., Vors, C., Harris, W. S., Jackson, K. H., Tchernof, A., Couture, P., & Lamarche, B. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519000552 · Cited by 20
Primary prevention of cardiovascular events in patients with major mental illness: a possible role for statins
Andrade, C. (2013) · Bipolar Disorders · doi:10.1111/bdi.12130 · Cited by 18
Statins in the elderly
Zoungas, S., Curtis, A. J., Tonkin, A. M., & McNeil, J. J. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000082 · Cited by 18
A dysglycaemic effect of statins in diabetes: relevance to clinical practice?
Swerdlow, D. I., & Sattar, N. A. (2014) · Diabetologia · doi:10.1007/s00125-014-3409-3 · Cited by 17
PCSK9 inhibition and LDL cholesterol lowering: the biology of an attractive therapeutic target and critical review of the latest clinical trials
Rhainds, D., Arsenault, B. J., & Tardif, J. (2012) · Clinical Lipidology · doi:10.2217/clp.12.74 · Cited by 18
Triple Combination Therapy for Global Cardiovascular Risk: Atorvastatin, Perindopril, and Amlodipine
Bertrand, M. E., Vlachopoulos, C. V., & Mourad, J. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0175-2 · Cited by 18
Should apolipoprotein B replace LDL cholesterol as therapeutic targets are lowered?
Meeusen, J. W., Donato, L. J., & Jaffe, A. S. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000313 · Cited by 17
Treatment of homozygous familial hypercholesterolemia
France, M. W., Schofield, J. D., Kwok, S., & Soran, H. (2014) · Clinical Lipidology · doi:10.2217/clp.13.79 · Cited by 15
Proprotein convertase subtilisin kexin type 9 inhibitors: update from clinical trials to real-world experience
Farnier, M. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000356 · Cited by 13
Statin use may improve clinicopathological characteristics and recurrence risk of invasive breast cancer
Şendur, M. A. N., Aksoy, S., Yazıcı, O., Özdemir, N., Zengin, N., & Altundağ, K. (2013) · Medical Oncology · doi:10.1007/s12032-013-0835-x · Cited by 12
Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline
Journath, G., Hambræus, K., Hagström, E., Pettersson, B., & Löthgren, M. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0659-2 · Cited by 12
Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin
Srisawasdi, P., Rodcharoen, P., Vanavanan, S., Chittamma, A., Sukasem, C., Nakorn, C. N., Dejthevaporn, C., & Kroll, M. H. (2021) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s278671 · Cited by 13
Prevention and control of cardiovascular disease in “real-world” settings: sustainable implementation of effective policies
Mendis, S., & Graham, I. M. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1380809 · Cited by 11
Systematic literature review and meta-analysis of dual therapy with fenofibrate or fenofibric acid and a statin versus a double or equivalent dose of statin monotherapy
Ouwens, M., Nauta, J. J. P., Ansquer, J.-C., & Driessen, S. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1098597 · Cited by 11
Blood-Pressure and Cholesterol Lowering in the HOPE-3 Trial
Lonn, E. M., Jung, H., & Yusuf, S. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1608916 · Cited by 11
Clinical Characteristics of Patients With Statin Discontinuation in Korea: A Nationwide Population-Based Study
Kim, K., Hong, S., Han, K., & Park, C. (2024) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2024.13.1.41 · Cited by 11
Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202
Verma, A., Bradford, Y., Verma, S. S., Pendergrass, S. A., Daar, E. S., Venuto, C. S., Morse, G. D., Ritchie, M. D., & Haas, D. W. (2017) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000263 · Cited by 9
Diet and cardiovascular health in asymptomatic normo- and mildly-to-moderately hypercholesterolemic participants – baseline data from the BLOOD FLOW intervention study
Hallikainen, M., Halonen, J., Konttinen, J., Lindholm, H. J., Simonen, P. P., Nissinen, M. J., & Gylling, H. K. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-62 · Cited by 9
Drug Development Strategy for Type 2 Diabetes: Targeting Positive Energy Balances
Liu, Z., & Yang, B. (2018) · Current Drug Targets · doi:10.2174/1389450120666181217111500 · Cited by 8
Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular disease
Weng, S. F., Akyea, R. K., Man, K. K. C., Lau, W. C. Y., Iyen, B., Blais, J. E., Chan, E. W., Siu, C. W., Qureshi, N., Wong, I. C. K., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260839 · Cited by 8
Persistent lipid abnormalities in patients with hypertension and dyslipidemia treated with statins: results of the Portuguese hypertensive subpopulation of the Dyslipidemia International Study (DYSIS)
Silva, P. M., Cardoso, S. M., & Ferreira, A. M. (2014) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2014.913605 · Cited by 8
Study of Consumer Acceptance About the Possible Commercialization of a Cheese with Berries
Ferrão, A. C., Guiné, R. P. F., & Correia, P. (2017) · Current Nutrition & Food Science · doi:10.2174/1573401313666170707103933 · Cited by 7
Drug treatment of dyslipidemia
Kim, S. (2016) · Journal of Korean Medical Association · doi:10.5124/jkma.2016.59.5.366 · Cited by 7
Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis
Galarza-Delgado, D. Á., Azpiri-Lopez, J. R., Colunga-Pedraza, I. J., la Garza, J. A. C., Vera‐Pineda, R., Garcia-Colunga, J. I., Arvizu‐Rivera, R. I., Martinez‐Moreno, A., Villarreal‐Pérez, J. Z., Elizondo‐Riojas, G., et al. (2016) · Clinical Rheumatology · doi:10.1007/s10067-016-3312-z · Cited by 7
Prevention of macrovascular disease in patients with short-duration type 2 diabetes by multifactorial target control: an 8-year prospective study
Wu, W., Ren, M., Cheng, H., Yan, L., Qi, Y., Yang, C. H., & Yan, L. (2014) · Endocrine · doi:10.1007/s12020-013-0158-x · Cited by 6

Authors: Mihaylova, B., Emberson, J., Keech, A., Collins, R., & Baigent, C.
Affiliations: University of Oxford (GB)
The University of Sydney (AU)
Corresponding author: Baigent, Colin
ORCID: Mihaylova, Borislava
Emberson, Jonathan
Keech, Anthony
Collins, Rory
Baigent, Colin
Venue: The Lancet
Publisher: Elsevier BV
Published: 2012-11
Volume: 380
Issue: 9856
Pages: 1817-1818
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(12)62027-3
OpenAlex: W2034831662
Cited by: 146
References: 5
Citations by year: 2026: 1 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 10 · 2020: 7 · 2019: 5 · 2018: 7 · 2017: 16 · 2016: 24 · 2015: 13 · 2014: 21 · 2013: 30 · 2012: 3
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Keywords: statins, low cardiovascular risk, LDL cholesterol lowering, major vascular events, coronary revascularization, atherosclerotic cardiovascular disease, all-cause mortality, cardiovascular risk assessment, meta-analysis bias, individual patient data meta-analysis, coronary artery disease, ischemic stroke, coronary death

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Statins for people at low risk of cardiovascular disease – Authors' reply

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks